|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02410 TYK MEDICINES-B
Nominal 
32.550 -2.550 (-7.265%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 107 | -- | 0 | 44,242 |
| Cost of Sales | (93) | -- | -- | (24,199) |
| Gross Profit | 14 | -- | -- | 20,043 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (60,758) | -21.895% | (77,790) | (69,112) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | |
| Profit / (Loss) before Taxation | (387,928) | 1.241% | (383,171) | (311,802) | |
| Taxation | 0 | -- | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 973 | 30.780% | 744 | 809 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (386,955) | 1.184% | (382,427) | (310,993) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 10,800 | -49.851% | 21,536 | 13,483 |
| Depreciation & Amortisation | 29,324 | 6.085% | 27,642 | 16,329 |
| Directors' Emoluments | -- | -- | 3,779 | 2,775 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | -115.000 | -- | -- | -- |
| DPS (cts) | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- |
| NBV per share ($) | 1.265 | -- | -- | -- |
| Remarks: | Real time quote last updated: 03/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -386,955,000 |
| %Change | 1.184% |
| EPS / (LPS) | RMB -1.150 |
| NBV Per Share (¥) | RMB 1.265 |